| First Author | Gantz SC | Year | 2021 |
| Journal | Elife | Volume | 10 |
| PubMed ID | 33822716 | Mgi Jnum | J:326475 |
| Mgi Id | MGI:6809000 | Doi | 10.7554/eLife.64241 |
| Citation | Gantz SC, et al. (2021) Excitation of medium spiny neurons by 'inhibitory' ultrapotent chemogenetics via shifts in chloride reversal potential. Elife 10:e64241 |
| abstractText | Ultrapotent chemogenetics, including the chloride-permeable inhibitory PSAM(4)-GlyR receptor, were recently proposed as a powerful strategy to selectively control neuronal activity in awake, behaving animals. We aimed to validate the inhibitory function of PSAM(4)-GlyR in dopamine D1 receptor-expressing medium spiny neurons (D1-MSNs) in the ventral striatum. Activation of PSAM(4)-GlyR with the uPSEM(792) ligand enhanced rather than suppressed the activity of D1-MSNs in vivo as indicated by increased c-fos expression in D1-MSNs and in vitro as indicated by cell-attached recordings from D1-MSNs in mouse brain slices. Whole-cell recordings showed that activation of PSAM(4)-GlyR depolarized D1-MSNs, attenuated GABAergic inhibition, and shifted the reversal potential of PSAM(4)-GlyR current to more depolarized potentials, perpetuating the depolarizing effect of receptor activation. These data show that 'inhibitory' PSAM(4)-GlyR chemogenetics may activate certain cell types and highlight the pitfalls of utilizing chloride conductances to inhibit neurons. |
